Evidence map›Paper›PMID 10523634›Full record

ArticleMolecular and cellular biology1999

Point mutations in yeast CBF5 can abolish in vivo pseudouridylation of rRNA.

Y Zebarjadian, T King, M J Fournier, L Clarke, J Carbon

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 126 papers.

0numbers the graph read from it
0cells of the map it votes in
126citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

126 citing papers in PubMed, 210 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Mapping of the Chemical Modifications of rRNAs.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  10. Review
  11. Review
  12. International journal of molecular sciences · 2021
    Review
  13. The role of mMolecular cancer · 2021
    Review
  14. Review
  15. Review
  16. Article
  17. Next generation sequencing reveals novel homozygous frameshift inSaudi journal of biological sciences · 2020
    Article
  18. Review
  19. Review
  20. Review

66 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Y ZebarjadianDepartment of Molecular Biology, University of California, Santa Barbara, California 93106, USA.
T King
M J Fournier
L Clarke
J Carbon
University of California, Santa Barbara · USUniversity of Massachusetts Amherst · US

Funding

BIOSYNTHESIS OF TRANSFER, 4.5S &6S RIBONUCLEIC ACIDSR01GM019351 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI FOURNIER, MAURILLE J · 1985 to 2008
$3.3M
STUDIES ON GENE ORGANIZATION AND EXPRESSIONR01CA011034 · NCI · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI CARBON, JOHN A · 1985 to 2007
$2.5M
CHROMOSOME SEGREGATION IN SCHIZOSACCHAROMYCES POMBER01GM033783 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI CLARKE, LOUISE B · 1985 to 1999
–
NCI NIH HHS CA11034NCI NIH HHS R01 CA011034NIGMS NIH HHS GM19351NIGMS NIH HHS GM33783NIGMS NIH HHS R01 GM019351
6 · The paper itself

Abstract

In budding yeast (Saccharomyces cerevisiae), the majority of box H/ACA small nucleolar RNPs (snoRNPs) have been shown to direct site-specific pseudouridylation of rRNA. Among the known protein components of H/ACA snoRNPs, the essential nucleolar protein Cbf5p is the most likely pseudouridine (Psi) synthase. Cbf5p has considerable sequence similarity to Escherichia coli TruBp, a known Psi synthase, and shares the "KP" and "XLD" conserved sequence motifs found in the catalytic domains of three distinct families of known and putative Psi synthases. To gain additional evidence on the role of Cbf5p in rRNA biosynthesis, we have used in vitro mutagenesis techniques to introduce various alanine substitutions into the putative Psi synthase domain of Cbf5p. Yeast strains expressing these mutated cbf5 genes in a cbf5Delta null background are viable at 25 degrees C but display pronounced cold- and heat-sensitive growth phenotypes. Most of the mutants contain reduced levels of Psi in rRNA at extreme temperatures. Substitution of alanine for an aspartic acid residue in the conserved XLD motif of Cbf5p (mutant cbf5D95A) abolishes in vivo pseudouridylation of rRNA. Some of the mutants are temperature sensitive both for growth and for formation of Psi in the rRNA. In most cases, the impaired growth phenotypes are not relieved by transcription of the rRNA from a polymerase II-driven promoter, indicating the absence of polymerase I-related transcriptional defects. There is little or no abnormal accumulation of pre-rRNAs in these mutants, although preferential inhibition of 18S rRNA synthesis is seen in mutant cbf5D95A, which lacks Psi in rRNA. A subset of mutations in the Psi synthase domain impairs association of the altered Cbf5p proteins with selected box H/ACA snoRNAs, suggesting that the functional catalytic domain is essential for that interaction. Our results provide additional evidence that Cbf5p is the Psi synthase component of box H/ACA snoRNPs and suggest that the pseudouridylation of rRNA, although not absolutely required for cell survival, is essential for the formation of fully functional ribosomes.

Indexed as

Point MutationRibonucleoproteins, Small NuclearRNA Processing, Post-TranscriptionalSaccharomyces cerevisiae ProteinsAmino Acid SequenceConserved SequenceHydro-LyasesMicrotubule-Associated ProteinsMolecular Sequence DataRibonucleoproteins, Small NucleolarRibosomesRNA-Binding ProteinsRNA Polymerase IIRNA PrecursorsRNA, RibosomalSaccharomyces cerevisiaeCBF5 protein, S cerevisiaeHydro-LyasesMicrotubule-Associated Proteinspseudouridylate synthetasepseudouridylic acidRibonucleoproteins, Small NuclearRibonucleoproteins, Small NucleolarRNA-Binding ProteinsRNA Polymerase IIRNA PrecursorsRNA, RibosomalSaccharomyces cerevisiae ProteinsUridine Monophosphate

Identifiers

PMID10523634
PMCPMC84741
OpenAlexW2126756655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.